Showing posts with label Pharmacopeias. Show all posts
Showing posts with label Pharmacopeias. Show all posts

Sunday, June 21, 2009

British National Formulary 56

Share


British National Formulary 56 Publisher:Pharmaceutical Press Pages:960 2008-10-11 ISBN:0853697787 CHM 7.4 MB
Published jointly by the BMJ Group and RPS Publishing (a wholly-owned publishing organisation of the Royal Pharmaceutical Society of Great Britain)Compiled with the advice of clinical experts, the British National Formulary (BNF) provides up-to-date guidance on prescribing, dispensing and administering medicines.The BNF details medicines prescribed in the UK, with special reference to their uses, cautions, contra-indications, side-effects, dosage and relative costs.Updated every six months, the BNF reflects current best practice as well as legal and professional guidelines relating to the use of medicines. It is intended for use by prescribers, pharmacists and other healthcare professionals.* Designed for rapid reference* Authoritative, impartial and, where available, evidence-based advice on prescribing, dispensing and administering medicines* Updated twice a year to reflect promptly changes in product availability as well as emerging safety concerns and shifts in clinical practice

Download for free

Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life (2006)

Share


Neonatal Formulary: Drug Use in Pregnancy and the First Year of LifePublisher:Humana Press Language: English ISBN:140514517X 320 pages Data: 2006 PDF 1 MbDescription: This title is now available for PDA, powered by Skyscape - to buy your copy Click hereThe Neonatal Formulary is a unique book providing advice on the safe use of drugs during pregnancy, labour and throughout the first year of life. Thoroughly updated, this fifth edition draws on the experience of an increasingly international group of neonatologists and is now a well established reference on prescribing in infancy. It covers all the drugs commonly used in the perinatal period, including those used for fetal treatment, and summarizes how the prescribing of each has to adapt to changes in drug elimination during the first year of life.

Neonatal Formulary

Share


Neonatal Formulary: Drugs in Pregnancy and the First Year of Life
Publisher:Bmj Publishing Group Pages:312 2003-01 ISBN:0727917382 PDF 1.7 MB
A compact and regularly updated reference with all the information doctors, midwives and nurses need to know about the prescribing of drugs, and their safe and accurate administration. Information on placental transfer, teratogenicity, and toxicity is provided for each listed drug, as is information on the extent to which the drug appears in breast milk (and the extent to which this matters). A whole page monograph is provided for all the commonly used drugs, blood products and vaccines and for a range of "orphan" drugs not mentioned in other standard formularies. There is also introductory advice on the management of suspected infection, renal failure, neonatal pain, circulatory and vascular problems and the control of seizures.

The International Pharmacopoeia, Third Edition

Share


The International Pharmacopoeia, Third Edition
Publisher: World Health Organization English ISBN: 9241545364 371 pages 2003-02-18 PDF 4 Mb
Presents an historical account of the Pharmacopoeia and describes methods and procedures for the quality control of pharmaceutical substances and dosage forms, including a special section on quality control of anti-malarials.

USP NF 2007 (United States Pharmacopeia/National

Share


US Pharmacopeial, ?USP NF 2007 (United States Pharmacopeia/National Formulary)?ISBN 1889788473 1 Har/Pap/ edition (May 2007) CHM 47 MbThe United States Pharmacopeia is a compendium of quality control tests for drugs and excipients to be introduced into a medicinal formulation. It is published every year [1] by the United States Pharmacopoeial Convention. It forms the basis of enforcement actions by the U.S. Food and Drug Administration and the U.S. Drug Enforcement Administration and is the official pharmacopoeia of the U.S.A. and many other nations. Therefore, in case of a dispute, those methods for, amongst others, identification, assay and purity determination of a drug substance or excipient which are stated in the USP will be the legally binding ones.Within the field the compendium is referred to simply as the USP. The initials USP are affixed to materials' names to indicate that they conform to the specifications in the USP and may be used medicinally.

European Pharmacopoeia, 4th edition

Share


The European Pharmacopoeia is a single reference work for the quality control of medicines in Europe. Several legal texts make the European Pharmacopoeia mandatory:A Convention on the Elaboration of a European Pharmacopoeia ratified in 2003 by 31 European countries and the European Union; European Union directives 2001/83/EC and 2001/82/EC,on medicines for human use and for veterinary use, respectively, maintain the mandatory character of European Pharmacopoeia specifications on medicines as regards their qualitative and quantitative composition and the tests to be carried out on these medicines, the raw materials used in production and the intermediates of synthesis. All producers of medicines or substances for pharmaceutical use therefore must apply the quality standards of the European Pharmacopoeia for the marketing and use of these products in Europe. The texts of the European Pharmacopoeia are legally binding and compliance is enforced by the administrative or juridical authorities. The national authorities of the member states are bound to apply them if necessary replacing any national monograph on the same subject. The 4th Edition consists of an initial volume 2002 (4.0) and a collection of 8 non-cumulative supplements (4.1) published three times a year following the decisions of each session of the European Pharmacopoeia Commission. With supplement 4.6, the 4th Edition comprises 1750 specific monographs, 285 general methods illustrated by figures or chromatograms and 2140 reagents. Every 4 months a new volume enters into force.